NCT00425243View on ClinicalTrials.gov

Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,025

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

zolpidem-MR (SL800750)

Trial Locations (1)

19355

Sanofi-Aventis, Malvern

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY